Effect of Arterial Cannulation on the Continuous and Non-invasive Hemoglobin Monitoring

Effect of Arterial Cannulation on the Continuous and Non-invasive Hemoglobin Monitoring for Laparoscopic Gastrectomy

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03957486

Enrollment

Registered

2019-05-21

Start date

2019-05-14

Completion date

2019-06-26

Last updated

2021-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Brief summary

The primary purpose of this study is to investigate the effect of arterial cannulation on the continuous and non-invasive hemoglobin monitoring during laparoscopic gastrectomy

Interventions

OTHERarterila cannulation on same arm

arterila cannulation on same arm receiving continous hemoglobin monitoring

OTHERarterila cannulation on different arm

arterila cannulation different arm receiving continous hemoglobin monitoring

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

19 Years to 85 Years

Healthy volunteers

Inclusion criteria

* Laparoscopic gastrectomy under general anesthesia

Exclusion criteria

* atypical hemoglobin disease, infective state, cardiovascular disease, peripheral vascular disease

Design outcomes

Primary

Measure	Time frame	Description
difference between SpHb value and SaHb value (SpHb - SaHb) in g/dL	3 time points from the start of anesthesia to the end of anesthesia, an average 2 hours	SpHb value (g/dL) is measured by co-oxymetry, and SaHb value (g/dL) is measured by blood sampling.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026